Companies will work together on critical components to accelerate client-sponsored validation programs through downstream drug development
Eurofins Announces the Completion of the Acquisition of Beacon Discovery, Inc.
Eurofins DiscoverX Extends Its Ordering Options Through Fisher Scientific Procurement
Eurofins DiscoverX announces Catalent Biologics as a North American Certified Biologics Analytical Laboratory
Eurofins DiscoverX announces partnership with VelaLabs through their Certified CRO Program for PathHunter® Bioassays that will enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions
Eurofins Acquires DiscoverX
Introducing PathHunter® iONCscan Services
Announcing the InCELL Pulse™ target engagement platform
Announcing the launch of the SAFETYscan™ in vitro pharmacological profiling services